Short-Term Dual Antiplatelet Therapy Followed by P2Y12 Monotherapy After Percutaneous Coronary Intervention: A Meta-Analysis of Randomized Control Trials

被引：0
|
作者：
Khan, Mohammad Saud [1 ,2 ]
Moustafa, Abdelmoniem [1 ,2 ]
Aronow, Herbert [3 ]
机构：
[1] Brown Univ, Miriam Hosp, Providence, RI USA
[2] Brown Univ, Alpert Med Sch, Providence, RI 02912 USA
[3] Lifespan Cardiovasc Inst, Providence, RI USA
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2020年 / 76卷 / 17期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
62
引用
收藏
页码：B26 / B27
页数：2
相关论文
共 50 条
  • [1] P2Y12 inhibitor monotherapy and dual antiplatelet therapy after percutaneous coronary intervention: An updated meta-analysis of randomized trials
    Jin, Yao
    Huang, Hui
    Shu, Xinyi
    Chen, Shuai
    Lu, Lin
    Gao, Xiang
    Wu, Zhijun
    THROMBOSIS RESEARCH, 2021, 198 : 115 - 121
  • [2] P2Y12 inhibitor monotherapy versus aspirin monotherapy after short-term dual antiplatelet therapy for percutaneous coronary intervention: Insights from a network meta-analysis of randomized trials
    Kuno, Toshiki
    Ueyama, Hiroki
    Takagi, Hisato
    Bangalore, Sripal
    AMERICAN HEART JOURNAL, 2020, 227 : 82 - 90
  • [3] Short Dual Antiplatelet Therapy Followed by P2Y12 Inhibitor Monotherapy versus 1-Year Dual Antiplatelet Therapy after Percutaneous Coronary Intervention: A Meta-Analysis of Randomized Controlled Trials
    Joseph, Meghna
    Krishna, Mrinal Murali
    Ezenna, Chidubem
    Pereira, Vinicius
    Franco, Ancy Jenil
    Goldsweig, Andrew
    CIRCULATION, 2024, 150
  • [4] P2Y12 Inhibitor Monotherapy After Short-Term Dual Antiplatelet Therapy in Acute Coronary Syndrome: A Meta-Analysis of Randomized Controlled Trials
    Garg, A.
    Singh, S.
    JACC-CARDIOVASCULAR INTERVENTIONS, 2024, 17 (04) : S10 - S10
  • [5] P2Y12 Inhibitor Monotherapy After Short-term Dual Antiplatelet Therapy in Patients Receiving Percutaneous Coronary Intervention
    Lone, Ahmad Naeem
    Khan, Safi U.
    CIRCULATION, 2020, 142
  • [6] Short-term dual antiplatelet therapy (DAPT) followed by P2Y12 monotherapy versus traditional DAPT in patients undergoing percutaneous coronary intervention: meta-analysis and viewpoint
    Wernly, Bernhard
    Rezar, Richard
    Gurbel, Paul
    Jung, Christian
    JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2020, 49 (01) : 173 - 176
  • [7] Short-term dual antiplatelet therapy (DAPT) followed by P2Y12 monotherapy versus traditional DAPT in patients undergoing percutaneous coronary intervention: meta-analysis and viewpoint
    Bernhard Wernly
    Richard Rezar
    Paul Gurbel
    Christian Jung
    Journal of Thrombosis and Thrombolysis, 2020, 49 : 173 - 176
  • [8] Meta-analysis of Dual Antiplatelet Therapy Versus Monotherapy With P2Y12 Inhibitors in Patients After Percutaneous Coronary Intervention
    Malik, Aaqib H.
    Yandrapalli, Srikanth
    Shetty, Suchith S.
    Aronow, Wilbert S.
    Cooper, Howard A.
    Panza, Julio A.
    AMERICAN JOURNAL OF CARDIOLOGY, 2020, 127 : 25 - 29
  • [9] Abbreviated Dual Antiplatelet Therapy Followed by P2Y12 Inhibitor Monotherapy versus 12 Months’ Dual Antiplatelet Therapy Post Percutaneous Coronary Intervention: A Systematic Review and Meta-analysis of Randomized Controlled Trials
    Ashish Kumar
    Mariam Shariff
    Rajkumar Doshi
    Igor Pedreira Vaz
    American Journal of Cardiovascular Drugs, 2020, 20 : 355 - 361
  • [10] P2Y12 INHIBITOR MONOTHERAPY VS. ASPIRIN MONOTHERAPY AFTER SHORT-TERM DUAL ANTIPLATELET THERAPY IN ELDERLY PATIENTS UNDERGOING PERCUTANEOUS CORONARY INTERVENTION: INSIGHTS FROM A NETWORK META-ANALYSIS OF RANDOMIZED TRIALS
    Uchiyama, Shuhei
    Ueyama, Hiroki
    Kuno, Toshiki
    Takagi, Hisato
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2021, 36 (SUPPL 1) : S152 - S153
12345